Ledger.Open graph →
SEC Form D · filed November 26, 2013

Avalanche Biotechnologies, Inc

Offering
$6.1M
Sold
$5.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Francisco, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Mark S. Blumenkranz · San Francisco, CADirectorThomas W. Chalberg · San Francisco, CAExec · DirectorMark S. Blumenkranz · Watertown, MADirectorSteven D. Schwarz · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗